Ali Tavassoli, Curve Therapeutics
"It's so refreshing to have the science come first. Universities and their funding models have changed over the past ten years - there's a lot more admin and red tape...science almost takes a bit of a back seat. Ideas that are high risk don't always get backed, [but in Biotech] things get done." Ali Tavassoli is the Chief Scientific Officer at Curve Therapeutics, a company developing a revolutionary intracellular screening platform to power drug discovery for challenging targets. Ali joined us to talk about his career, balancing academic work with building a Biotech company, resisting the pressure to publish when tackling major scientific challenges, and why following the science is crucial in building your life's work. Enjoy!